Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001497093 | SCV001701810 | likely benign | not provided | 2023-12-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001497093 | SCV002586170 | benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | ANLN: BS1, BS2 |
Fulgent Genetics, |
RCV002501709 | SCV002809601 | likely benign | Focal segmental glomerulosclerosis 8 | 2022-05-13 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003980436 | SCV004795185 | likely benign | ANLN-related disorder | 2020-08-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |